Extend Medicare prescription drug cost savings, including lower negotiated prices and caps on insulin and out-of-pocket drug costs, to all Americans.

Suzan K. DelBene · Washington · Democratic

policy impact 0.73 specificity 0.75 extraction confidence 90%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

Moving forward, we must extend these hard-fought cost savings to all Americans, not just those with Medicare.

DelBene commits to extending Medicare drug cost savings beyond Medicare recipients to all Americans.

Health Care - Delbene For Congress
campaign · campaign_site · model gpt-5.5

Evidence

legacy_unverified · Source version not recorded · locator unknown

GovInfo lists H.R. 6166 as introduced in the House on November 20, 2025 and referred to the Energy and Commerce, Ways and Means, and Education and Workforce committees. Its full title would expand Medicare drug price negotiation, apply Medicare prescription drug inflation rebates to the commercial market, and establish prescription drug out-of-pocket limits under private health insurance.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The bill matches the promise’s mechanism for extending Medicare drug-cost savings to privately insured Americans, but the official record shown is still the introduced House bill with committee referral, not enacted law.

unresolved same_term A for effort

H.R. 6166 (IH) - Lowering Drug Costs for American Families Act
secondary · model gpt-5.5 · confidence 86%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

DelBene’s campaign health-care page says Medicare reforms now allow negotiated prescription drug prices, a $35 monthly insulin cap, and a $2,000 annual out-of-pocket cap for seniors, then states that these cost savings must be extended to all Americans, not just Medicare beneficiaries.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): This establishes the current promise and also frames the remaining gap: the listed savings exist for Medicare beneficiaries, while the broader all-Americans extension remains an agenda item.

unresolved same_term

Health Care - Delbene For Congress
campaign · model gpt-5.5 · confidence 80%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): unresolved. unknown A for effort

The promised Medicare drug-cost savings exist for Medicare beneficiaries, but that does not fulfill the specific promise to extend negotiated prices, insulin caps, and out-of-pocket prescription drug caps to all Americans. H.R. 6166 appears to match the promised extension and DelBene cosponsored it on December 18, 2025, but the bill remains at the introduced/referred-to-committee stage with no enactment shown. Because the relevant federal legislation is still pending rather than failed or delivered, the outcome is unresolved with effort credit.

provider codex_cli · model gpt-5.5 · confidence 87%